Back to Search
Start Over
T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
- Source :
-
Journal of leukocyte biology [J Leukoc Biol] 2022 Jan; Vol. 111 (1), pp. 269-281. Date of Electronic Publication: 2021 Feb 02. - Publication Year :
- 2022
-
Abstract
- The immune system plays a crucial role in the response against severe acute respiratory syndrome coronavirus 2 with significant differences among patients. The study investigated the relationships between lymphocyte subsets, cytokines, and disease outcomes in patients with coronavirus disease 2019 (COVID-19). The measurements of peripheral blood lymphocytes subsets and cytokine levels were performed by flow cytometry for 57 COVID-19 patients. Patients were categorized into two groups according to the severity of the disease (nonsevere vs. severe). Total lymphocytes, T cells, CD4+ T cells, CD8+ T cells, B cells, and natural killer cells were decreased in COVID-19 patients and statistical differences were found among different severity of illness and survival states (P ˂ 0.01). The levels of IL-6 and IL-10 were significantly higher in severe and death groups and negatively correlated with lymphocyte subsets counts. The percentages of Th17 in the peripheral blood of patients were higher than those of healthy controls whereas the percentages of Th2 were lower. For the severe cases, the area under receiver operating characteristic (ROC) curve of IL-6 was the largest among all the immune parameters (0.964; 95% confidence interval: 0.927-1.000, P < 0.0001). In addition, the preoperative IL-6 concentration of 77.38 pg/ml was the optimal cutoff value (sensitivity: 84.6%, specificity: 100%). Using multivariate logistic regression analysis and ROC curves, IL-6 > 106.44 pg/ml and CD8+ T cell counts <150 cells/μl were found to be associated with mortality. Measuring the immune parameters and defining a risk threshold can segregate patients who develop a severe disease from those with a mild pathology. The identification of these parameters may help clinicians to predict the outcome of the patients with high risk of unfavorable progress of the disease.<br /> (©2021 Society for Leukocyte Biology.)
- Subjects :
- Africa, Northern
Aged
Biomarkers blood
CD8-Positive T-Lymphocytes immunology
COVID-19 immunology
Cytokines metabolism
Female
Humans
Kaplan-Meier Estimate
Lymphocyte Count
Lymphocyte Subsets immunology
Male
Middle Aged
Multivariate Analysis
Prognosis
Treatment Outcome
COVID-19 blood
COVID-19 mortality
Interleukin-6 blood
Severity of Illness Index
Subjects
Details
- Language :
- English
- ISSN :
- 1938-3673
- Volume :
- 111
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Journal of leukocyte biology
- Publication Type :
- Academic Journal
- Accession number :
- 33527487
- Full Text :
- https://doi.org/10.1002/JLB.4COVA1020-703R